Company Number: 12936978

Analysis Date: 2025-07-20 13:52 UTC

1. Credit Opinion: DECLINE
   Ayurituals Ltd shows a persistently negative net asset position and working capital deficits over the last three years, indicating financial distress. The company’s cash position is negative and deteriorating, reflecting an inability to generate sufficient liquidity to meet short-term liabilities. As a start-up in the artistic creation and jewellery manufacturing sectors, it exhibits weak financial resilience and no indication of profitability or recovery in filings. The single director and founder holds significant control but the lack of equity and recurring losses suggest limited financial stewardship capacity to service credit obligations. Given these factors, extending credit facilities would be high risk at this stage.

2. Financial Strength:

• Shareholders’ funds are negative at -£21,197 (2023) worsening from -£18,584 (2022), indicating accumulated losses exceeding capital invested.
• Net current liabilities stand at -£21,197, showing insufficient current assets to cover short-term debts.
• The company holds no fixed assets or reported investments; all assets are current and inadequate to meet obligations.
• Share capital is nominal (£2), signalling minimal equity buffer.
• The financial trend is negative with no signs of improvement or profitability disclosed.

3. Cash Flow Assessment:

• Cash balances are negative at -£19,477 (2023), worsening from -£18,062 (2022), implying overdraft or unpaid liabilities.
• Current liabilities increased from £520 to £1,720, further straining liquidity.
• Negative working capital suggests the company is reliant on external funding or director support to meet immediate cash demands.
• No evidence of cash inflows or operational cash generation to offset outflows.

4. Monitoring Points:

• Improvements in net current assets and cash balances to positive territory.
• Development of consistent positive cash flow from operations.
• Reduction in accumulated losses and movement toward positive shareholder funds.
• Evidence of increased sales or contracts improving turnover and profitability.
• Changes in management or capital injection that could stabilize finances.